Anticonvulsant-induced psychiatric disorders. The role of forced normalisation

Drug Safety

Volumn 15, Issue 3, 1996, Pages 159-166

  Trimble, Michael R ^a,b  

^a NATIONAL HOSPITAL FOR NEUROLOGY AND NEUROSURGERY   (United Kingdom)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICONVULSIVE AGENT; CARBAMAZEPINE; CLOBAZAM; CLONAZEPAM; ETHOSUXIMIDE; GABAPENTIN; LAMOTRIGINE; PHENOBARBITAL; PHENYTOIN; TIAGABINE; TOPIRAMATE; VALPROIC ACID; VIGABATRIN; ZONISAMIDE;

AFFECTIVE NEUROSIS; AGITATION; ATTENTION DEFICIT DISORDER; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEPRESSION; EPILEPSY; HUMAN; HYPERACTIVITY; MAJOR CLINICAL STUDY; MENTAL DISEASE; META ANALYSIS; MOOD; PERSONALITY DISORDER; PRIORITY JOURNAL; PSYCHOSIS; REVIEW;

EID: 0029839918     PISSN: 01145916     EISSN: None     Source Type: Journal    
DOI: 10.2165/00002018-199615030-00001     Document Type: Review

References (47)

1. Glaus A. Über Kombinatione von Schizophrenie und Epilepsie. Z Gesamte Neurol Psychiatr 1931; 135: 450-500
2. Wolf P, Trimble MR. Biological antagonism and epileptic psychosis. Br J Psychiatry 1985; 146: 272-6
3. Landolt H. Serial EEG investigations during psychotic episodes in epileptic patients and during schizophrenic attacks. In: de Haas AML, editor. Lectures on epilepsia. Amsterdam: Elsevier, 1958: 91-133
4. Gibbs FA. Ictal and nonictal psychiatric disorders in temporal lobe epilepsy. J Nerv Ment Dis 1951; 113: 522-8
5. Tellenbach H. Epilepsia als Anfallsleiden und Als Psychose der Nervenarzt. Der Nervenarzt 1965; 36: 190-202
6. Amin N, Gross-Tsur V. Paradoxical normalisation in childhood epilepsy. Epilepsia 1994; 35: 1060-4
7. Trimble MR. The psychoses of epilepsy. New York: Raven Press, 1991
8. Reynolds EH, Travers RD. Serum anticonvulsant concentrations in epileptic patients with mental symptoms. Br J Psychiatry 1974; 124: 440-5
9. Thompson PM, Trimble MR. Epilepsy. In: Grant I, Adams KM, editors. Neuropsychological assessment of neuropsychiatric disorders. Oxford: Oxford University Press. In press
10. Rodin E, Schmaltz S. The Bear-Fedio personality inventory and temporal lobe epilepsy. Neurology 1984; 34: 591-6
11. Rodin EA, Katz ME, Lennox K. Differences between patients with temporal lobe seizures and those with other forms of epileptic attacks. Epilepsia 1976; 17: 313-20
12. Dodrill CB, Troupin AS. Psychotropic effects of carbamazepine in epilepsy: a double blind comparison with phenytoin. Neurology 1977; 27: 1023-8
13. Thompson PJ, Trimble MR. Anticonvulsant drugs and cognitive function. Epilepsia 1982; 23: 531-45
14. Andrewes DG, Bullen JG, Tomlinson L, et al. A comparative study of the cognitive effects of phenytoin and carbamazepine in new referrals with epilepsy. Epilepsia 1986; 27: 128-34
15. Robertson MM, Trimble MR, Townsend HRA. The phenomenology of depression in epilepsy. Epilepsia 1987 28: 364-72
16. Brent DA, Crumrine PK, Varma RR, et al. Phenobarbital treatment and major depressive disorder in children with epilepsy. Paediatrics 1987; 80: 99-107
17. American Psychiatric Association. Diagnostics and statistical Manual of mental disorders. 3rd ed. Washington DC: American Psychiatric Association, 1980
18. Chadwick D. Paper presented at the Merritt-Putman Symposium, International Epilepsy Congress, Sydney, 1995. Epilepsia. In press
19. Topamax product monograph. New Jersey: Zola Associates, Cilag International, 1995
20. Ring HA, Crellin R, Kirker S, et al. Vigabatrin and depression. J Neurol Neurosurg Psychiatry 1994; 56: 925-8
21. Thomas L, Trimble MR, Schmitz B, et al. Vigabatrin and behaviour disorders: a retrospective study. Epilepsy Res. In press
22. Short C, Cook L. Hypomania induced by gabapentin. Br J Psychiatry 1995; 166: 679-80
23. Weisler RH, Risner M, Ascher J, et al. The use of lamotrigine in the treatment of bipolar disorder. In: New research programme and abstracts. American Psychiatric Association Annual Meeting, Philadelphia, 1994. New Research Abstract 611
24. Baker GA, Jacoby A, Smith D, et al. Quality of life in epilepsy: the Liverpool initiative. In: Trimble MR, Dodson WE, editors. Quality of life. New York: Raven Press, 1995: 135-50
25. Trimble MR. Biological psychiatry. 2nd ed. Chichester: J Wiley & Sons, 1996
26. Post RM, Weiss SRB. Kindling and manic depressive illness. In: Bolwig TG, Trimble MR, editor. The clinical relevance of kindling. Chichester: J Wiley & Sons, 1989: 209-30
27. Ketter TA, George MS, Ring HA, et al. Primary mood disorders: structural and resting functional studies. Psychiatric Annals 1994; 24: 637-42
28. Reynolds EH. Neurological aspects of folate and vitamin B12 metabolism. Clin Haematol 1976; 5: 661-96
29. Trimble MR, Reynolds EH. Neuropsychiatric toxicity of anticonvulsant drugs. In: Matthews WB, Glaser GH, editors. Recent advances in clinical neurology. Edinburgh: Churchill Livingstone, 1984: 161-80
30. Pratt JA, Jenner P, Johnson AL, et al. Anticonvulsant drugs alter plasma tryptophan concentrations in epileptic patients. J Neurol Neurosurg Psychiatry 1984; 47: 1131-3
31. Drake ME, Peruzzi WT. Manic state with carbamazepine therapy of seizures. J Natl Med Assoc 1986; 78: 1105-07
32. Palkanis A, Drake ME, Kuruvilla J, et al. Forced normalisation. Arch Neurol 1987; 44: 289-92
33. Kugoh T, Watanabe M, Obayashi K. Two cases with epilepsy who manifested manic depressive symptoms under barbiturate treatment. Jpn J Psychiatry Neurol 1991; 45: 437-8
34. McDanal CE, Bolman WM. Delayed idiosyncratic psychosis with diphenylhydantoin. JAMA 1975; 231: 1063
35. Fischer M, Korskjeer G, Pederson. Psychotic episodes with Zaronden treatment. Epilepsia 1965; 6: 325-34
36. Roger J, Grangeon H, Guey J, et al. Incidences psychiatriques et psychologiques du traitment par l'éthosuccimide chez les épileptiques. Encéphale 1968; 57: 407-38
37. Wolf P, Trimble MR. Biological antagonism and epileptic psychosis. Br J Psychiatry 1985; 146: 272-6
38. Wolf P. Acute behavioural symptomatology at disappearance of epileptiform EEG abnormality: paradoxical or forced normalisation. In: Smith D, Treiman D, Trimble MR, editors. Neurobehavioural problems in epilepsy. New York: Raven Press, 1991: 127-42
39. McConnell H, Duffy J, Snyder PJ, et al. Neuropsychiatric presentations of felbamate. J Neuropsychiatry Clin Neurosci. In press
40. Brown S. Management issues in treating adults with lamotrigine. In: Reynolds EH, editor. Lamotrigine, a new advance in the treatment of epilepsy. London: Royal Society of Medicine, 1993. International Congress and Symposium Series; 204: 95-101
41. Martin M, Muatnoz-Blanco JL, Lopez-Arizteuzi N. Acute psychosis induced by lamotrigine [abstract]. Epilepsia 1995; 36 Suppl. 3: 118
42. Sander JWAS, Hart YM, Trimble MR, et al. Vigabatrin and psychosis. J Neurol Neurosurg Psychiatr 1991; 54: 435-9
43. Tsuji M, Hori S, Asai N, et al. Two epileptics showing antiepileptic drug induced psychoses. Jpn J Psychiatry Neurol 1993; 47: 298-9
44. Kimura S. Zonisamide induced behaviour disorder in two children. Epilepsia 1994; 35: 403-5
45. Ferrie CD, Robinson RO, Panayiotopoulos CP. Psychiatric and severe behavioural reactions with vigabatrin: a review. Acta Neurol Stand 1996; 93: 1-8
46. Matsuo F, Bergen D, Faught E, et al. Placebo-controlled study of the efficiency and safety of lamotrigine in patients with partial seizures. Neurology 1993; 43: 2284-91
47. Cockrell DC, Moriarty J, Trimble MR, et al. Acute psychological disorders in patients with epilepsy: a nationwide study. Epilepsy Res. In press